Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Plos One|February 11, 2026
Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting systemFengjiao Kang, Yin Wang, Fengqun Cai, et al.
BMC Health Services Research|January 15, 2024
Establishing a trigger tool based on global trigger tools to identify adverse drug events in obstetric inpatients in ChinaShan Wu, Qinan Yin, Liuyun Wu, et al.
Frontiers in Pharmacology|January 8, 2024
Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseasesQinan Yin, Xingyue Zheng, Yujie Song, et al.
Frontiers in Immunology|June 12, 2023
Immune-related adverse events of immune checkpoint inhibitors: a reviewQinan Yin, Liuyun Wu, Lizhu Han, et al.
Frontiers in Pharmacology|March 17, 2025
Development and validation of a prediction model for VTE risk in gastric and esophageal cancer patientsXingyue Zheng, Liuyun Wu, Lian Li, et al.
Frontiers in Pharmacology|November 24, 2025
Development of a venous thromboembolism risk prediction model for patients with primary membranous nephropathy based on machine learningLian Li, Liuyun Wu, Yin Wang, et al.
Frontiers in Medicine|October 16, 2023
Adverse drug events in Chinese elder inpatients: a retrospective review for evaluating the efficiency of the Global Trigger ToolNan Yu, Liuyun Wu, Qinan Yin, et al.
Frontiers in Pharmacology|December 8, 2025
Comparative efficacy and safety of second-line therapies for patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis of randomized controlled trialsFengjiao Kang, Yin Wang, Fengqun Cai, et al.
International Journal of Surgery (London, England)|February 12, 2026
Revolutionizing anticoagulation: DOAC versus VKA in atrial fibrillation with early post-bioprosthetic valves replacement or valves repairLizhu Han, Yin Wang, Hulin Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 28, 2024
A promising therapy for fatty liver disease: PCSK9 inhibitorsLizhu Han, Liuyun Wu, Qinan Yin, et al.
Pageof 2